Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease-Report of the JPND Working Group BioLoC-PD

Neuroepidemiology

Volumn 45, Issue 4, 2015, Pages 282-297

  Lerche, Stefanie ^a,b   Liepelt Scarfone, Inga ^a,b   Alves, Guido ^h   Barone, Paolo ⁱ   Behnke, Stefanie ^c   Ben Shlomo, Yoav ^k   Berendse, Henk ^j   Burn, David ^l   Dodel, Richard ^d   Grosset, Donald ^m   Heinzel, Sebastian ^a,b   Hu, Michele ⁿ   Kasten, Meike ^e   Krüger, Rejko ^o   Maetzler, Walter ^a,b   Moccia, Marcello ⁱ   Mollenhauer, Brit ^f   Oertel, Wolfgang ^d   Roeben, Benjamin ^a,b   Sünkel, Ulrike ^a,b   Walter, Uwe ^g   Wirdefeldt, Karin ^p   Berg, Daniela ^a,b   more..

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e UNIVERSITY OF LÜBECK   (Germany)

^f UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^g UNIVERSITY OF ROSTOCK   (Germany)

^h STAVANGER UNIVERSITY HOSPITAL   (Norway)

ⁱ UNIVERSITY OF SALERNO   (Italy)

^j VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^k Department of Social Medicine ^*  (United Kingdom)

^l Newcastle University Campus for Ageing and Vitality   (United Kingdom)

^m SOUTHERN GENERAL HOSPITAL   (United Kingdom)

ⁿ UNIVERSITY OF OXFORD   (United Kingdom)

^o Head of Clinical and Experimental Neuroscience   (Luxembourg)

^p KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

Cohort studies; Longitudinal; Marker; Parkinson's disease

Indexed keywords

ANXIETY DISORDER; ARTICLE; COGNITION; COLOR VISION; CONSENSUS; DAILY LIFE ACTIVITY; DEPRESSION; FOLLOW UP; GASTROINTESTINAL TRACT FUNCTION; HUMAN; LONGITUDINAL STUDY; MOTOR PERFORMANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRODROMAL SYMPTOM; QUESTIONNAIRE; RISK; SLEEP; SMELLING; STUDY DESIGN; DISEASE COURSE; EUROPE; METHODOLOGY;

BIOLOGICAL MARKER;

BIOMARKERS; DISEASE PROGRESSION; EUROPE; HUMANS; LONGITUDINAL STUDIES; PARKINSON DISEASE; PRODROMAL SYMPTOMS; RESEARCH DESIGN;

EID: 84946771709     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000439221     Document Type: Article

References (30)

1. Martínez-Martín P, et al: Unified Parkinson's disease rating scale characteristics and structure. The cooperative multicentric group. Mov Disord 1994; 9: 76-83.
2. Goetz CG, et al: Movement disorder society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDSUPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23: 2129-2170.
3. Ross GW, et al: Pre-motor features of Parkinson's disease: the Honolulu-Asia aging study experience. Parkinsonism Relat Disord 2012; 18(suppl 1):S199-S202.
4. Maetzler W, Hausdorff JM: Motor signs in the prodromal phase of Parkinson's disease. Mov Disord 2012; 27: 627-633.
5. Iranzo A, et al: Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 2013; 12: 443-453.
6. Goetz CG, Stebbins GT, Tilley BC: Calibration of unified Parkinson's disease rating scale scores to movement disorder society-unified Parkinson's disease rating scale scores. Mov Disord 2012; 27: 1239-1242.
7. Maetzler W, et al: Quantitative wearable sensors for objective assessment of Parkinson's disease. Mov Disord 2013; 28: 1628-1637.
8. Leentjens AF, et al: Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 2003; 18: 414-418.
9. Aarsland D, et al: The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. J Neurol Neurosurg Psychiatry 2009; 80: 928-930.
10. Barone P, et al: The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009; 24: 1641-1649.
11. van Steenoven I, et al: Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease. Mov Disord 2014; 29: 1809-1815.
12. Lessig S, et al: Changes on brief cognitive instruments over time in Parkinson's disease. Mov Disord 2012; 27: 1125-1128.
13. Kandiah N, et al: Montreal cognitive assessment for the screening and prediction of cognitive decline in early Parkinson's disease. Parkinsonism Relat Disord 2014; 20: 1145-1148.
14. Hoops S, et al: Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009; 73: 1738-1745.
15. Litvan I, et al: Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines. Mov Disord 2012; 27: 349-356.
16. Dubois B, et al: Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007; 22: 2314-2324.
17. Doty RL: Olfaction in Parkinson's disease and related disorders. Neurobiol Dis 2012; 46: 527-552.
18. Ponsen MM, et al: Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease. J Neurol Neurosurg Psychiatry 2010; 81: 396-399.
19. Johns MW: A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-545.
20. Ahmed AE, et al: Validation of the Arabic version of the Epworth sleepiness scale. J Epidemiol Glob Health 2014; 4: 297-302.
21. Surani AA, et al: Validation of the Urdu version of the Epworth sleepiness scale. J Pak Med Assoc 2012; 62: 986-988.
22. Beiske KK, et al: Reliability and validity of a Norwegian version of the Epworth sleepiness scale. Sleep Breath 2009; 13: 65-72.
23. Postuma RB, et al: How does parkinsonism start Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain 2012; 135(pt 6):1860-1870.
24. Kim YE, Jeon BS: Clinical implication of REM sleep behavior disorder in Parkinson's disease. J Parkinsons Dis 2014; 4: 237-244.
25. Ratti PL, et al: REM and NREM sleep enactment behaviors in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. Sleep Med 2012; 13: 926-932.
26. Arnulf I, Leu-Semenescu S: Sleepiness in Parkinson's disease. Parkinsonism Relat Disord 2009; 15(suppl 3):S101-S104.
27. Stiasny-Kolster K, et al: The REM sleep behavior disorder screening questionnaire-a new diagnostic instrument. Mov Disord 2007; 22: 2386-2393.
28. Stiasny-Kolster K, et al: Diagnostic value of the REM sleep behavior disorder screening questionnaire in Parkinson's disease. Sleep Med 2015; 16: 186-189.
29. Berg D, et al: Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons. Arch Neurol 2011; 68: 932-937.
30. Kolen MJ, Brennan RL: Test Equating, Scaling and Linking: Methods and Practices. New York, Springer, 2004.